Guidance
Frequently Asked Questions (FAQ) on use of fractional dosing with intradermal administration of mpox MVA-BN vaccine in the context of vaccine supply-constrained outbreak response
This document outlines key considerations for the use of fractional dosing with intradermal administration of the MVA-BN mpox vaccine in response to ongoing mpox outbreaks. In light of the limited availability of vaccine and current WHO recommendations, national authorities may, as a temporary outbreak response measure, consider administering MVA-BN vaccine via intradermal injection at a reduced dose to protect individuals at risk of exposure.
Authors
Languages
- English
Publication year
2025
Type
Guidance
Categories
- Vaccines & delivery devices
Diseases
- Mpox
Organisations
- World Health Organization (WHO)
Tags
- Emergencies
- Outbreak
- Vaccine management
- Vaccine supply
WHO Regions
- African Region
Mpox-Policy
You can find more information about "Mpox-Policy" in the following Hot Topics:
